Dose escalation of cisplatin (P) , etoposide (E) , and ifosfamide (I) with GM-CSF for advanced germ cell tumors
Schmoll, H.J.; Bokemeyer, C.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Ruther, U.; Osternamm, A.; Preiss, J.; Wilke, H.; Hohnloser, J.
Pathologie-Biologie 39(9): 961
1992
ISSN/ISBN: 0369-8114 PMID: 1538953 Document Number: 388238
Document emailed within 1 workday
Related Documents
Athanassiou, A.E.; Potamianou, A.; Bountouroglou, N.; Ziras, N.; Frangoulidis, A.; Varthalitis, J.; Karvounis, N.; Chrysanthou, C.; Pectasidis, D. 2002: Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): an effective first-line therapy for IGCCC intermediate / poor prognosis patients with germ-cell tumors. Single institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 7(1): 35-41Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Bosl, G.J.; Bajorin, D.F. 1994: Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison Seminars in Oncology 21(5 Suppl 12: 61-64
Donato, M.L.; Champlin, R.E.; Wharton, J.T.; Bodurka-Bevers, D.; Gershenson, D. 2000: Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer European Journal of Gynaecological Oncology 21(3): 241-244
Kumano, M.; Miyake, H.; Hara, I.; Muramaki, M.; Takenaka, A.; Fujisawa, M. 2007: Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy Hinyokika Kiyo. Acta Urologica Japonica 53(12): 851-856
Lee, H-W.; Choi, J-H.; Lim, H-Y.; Park, J.S.; Kim, H.C.; Kang, S.; Oh, Y.T.; Chun, M.; Sheen, S.S.; Oh, Y.J.; Park, K.J.; Hwang, S.C. 2006: The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis Neoplasma 53(1): 30-36
Ardizzoni, A.; Canobbio, L.; Pronzato, P.; Rubagotti, A.; De Palma, M.; Baracco, F.; Serrano, J.; Serrano, S.; Faravelli, B.; Nosenzo, M. 1986: Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung Cancer Treatment Reports 70(7): 891-892
Marwaha, S.; Venner, P.M.; North, S.A. 2007: The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse Canadian Journal of Urology 14(5): 3692-3696
Cosmas, C.; Tsavaris, N.; Malamos, N.; Tsakonas, G.; Gassiamis, A.; Skopelitis, H.; Soukouli, G.; Polyzos, A.; Mylonakis, N.; Karabelis, A. 2005: Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 10(3): 337-346
Perez, E.A.; Gandara, D.R. 1994: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 2-5
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631
Hashimoto, H.; Tokumitsu, M.; Morikawa, M.; Numata, A.; Yachiku, S.; Iuchi, H.; Yamauchi, K. 1996: Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(7): 941-944
Fennelly, D.W.; Aghajanian, C.; Shapiro, F.; O'Flaherty, C.; O'Connor, K.; Curtin, J.P.; Crown, J.P.; Hoskins, W.J.; Spriggs, D.R. 1997: Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Yuki, K.; Kodama, Y.; Emoto, K.; Yukawa, O.; Onda, J.; Uozumi, T. 1989: A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Pt 1): 2651-2654
Soh, L.T.; Tan, E.H.; Ang, P.T. 1998: Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer Singapore Medical Journal 39(8): 357-358
Palackdharry, C.S.; Krigel, R.L. 1994: Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 6-11
Matsukado, Y.; Abe, H.; Tanaka, R.; Kobayashi, T.; Yamashita, J.; Nishimoto, A.; Ushio, Y.; Sato, K.; Matsutani, M.; Takakura, K. 1986: Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group Gan No Rinsho. Japan Journal of Cancer Clinics 32(11): 1387-1393
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Fujita, A.; Igami, Y.; Takabatake, H.; Tagaki, S.; Yamamoto, R.; Sekine, K. 1999: Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 805-811
Kanamori, M.; Kumabe, T.; Saito, R.; Yamashita, Y.; Sonoda, Y.; Tominaga, T. 2010: The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases No Shinkei Geka. Neurological Surgery 38(11): 997-1005